These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23875313)

  • 21. Prebiotics, probiotics and digestive health.
    Balakrishnan M; Floch MH
    Curr Opin Clin Nutr Metab Care; 2012 Nov; 15(6):580-5. PubMed ID: 23037903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Butyrate-producing bacteria as pharmabiotics for inflammatory bowel disease.
    Marteau P
    Gut; 2013 Dec; 62(12):1673. PubMed ID: 23461897
    [No Abstract]   [Full Text] [Related]  

  • 23. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of exopolysaccharide-producing probiotic strains on experimental colitis in rats.
    Sengül N; Aslím B; Uçar G; Yücel N; Işik S; Bozkurt H; Sakaoğullari Z; Atalay F
    Dis Colon Rectum; 2006 Feb; 49(2):250-8. PubMed ID: 16362802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. H2 and acetate transfers during xylan fermentation between a butyrate-producing xylanolytic species and hydrogenotrophic microorganisms from the human gut.
    Chassard C; Bernalier-Donadille A
    FEMS Microbiol Lett; 2006 Jan; 254(1):116-22. PubMed ID: 16451188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prebiotics, synbiotics and inflammatory bowel disease.
    Steed H; Macfarlane GT; Macfarlane S
    Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidants keep the potentially probiotic but highly oxygen-sensitive human gut bacterium Faecalibacterium prausnitzii alive at ambient air.
    Khan MT; van Dijl JM; Harmsen HJ
    PLoS One; 2014; 9(5):e96097. PubMed ID: 24798051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Butyrate: implications for intestinal function.
    Leonel AJ; Alvarez-Leite JI
    Curr Opin Clin Nutr Metab Care; 2012 Sep; 15(5):474-9. PubMed ID: 22797568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nongastric Helicobacter species detected in the intestinal tract of children.
    Zhang L; Day A; McKenzie G; Mitchell H
    J Clin Microbiol; 2006 Jun; 44(6):2276-9. PubMed ID: 16757639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory bowel disease, a dysregulated host-microbiota interaction: are probiotics a new therapeutic option?
    Howarth GS
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1777-9. PubMed ID: 19120868
    [No Abstract]   [Full Text] [Related]  

  • 31. Survival and metabolic activity of selected strains of Propionibacterium freudenreichii in the gastrointestinal tract of human microbiota-associated rats.
    Lan A; Bruneau A; Philippe C; Rochet V; Rouault A; Hervé C; Roland N; Rabot S; Jan G
    Br J Nutr; 2007 Apr; 97(4):714-24. PubMed ID: 17349084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production and Sensing of Butyrate in a Probiotic
    Bai Y; Mansell TJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Column bioleaching of low-grade mining ore containing high level of smithsonite, talc, sphaerocobaltite and azurite.
    Ilyas S; Chi R; Bhatti HN; Bhatti IA; Ghauri MA
    Bioprocess Biosyst Eng; 2012 Mar; 35(3):433-40. PubMed ID: 21947702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?
    Marteau P
    Gut; 2006 Dec; 55(12):1692-3. PubMed ID: 17124152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
    Mitsuyama K; Sata M
    Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats.
    Schultz M; Munro K; Tannock GW; Melchner I; Göttl C; Schwietz H; Schölmerich J; Rath HC
    Clin Diagn Lab Immunol; 2004 May; 11(3):581-7. PubMed ID: 15138186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease.
    Gassull MA
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():90-5. PubMed ID: 16961752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotics in inflammatory bowel disease--therapeutic rationale and role.
    Shanahan F
    Adv Drug Deliv Rev; 2004 Apr; 56(6):809-18. PubMed ID: 15063591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future.
    Shanahan F
    Br J Nutr; 2002 Sep; 88 Suppl 1():S5-9. PubMed ID: 12215176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ileal effluent as a fermentation substrate: implications for butyrate production in the colon.
    Robertson JA; Ryden P; Botham L; Ring S
    J Environ Pathol Toxicol Oncol; 1999; 18(2):141-6. PubMed ID: 15281226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.